SCHEMBL6544531

SCHEMBL6544531

C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CBr

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 8/20 0.85
▸ NR3C1 P04150 4/20 0.85
▸ SERPINA6 P08185 4/20 0.85
▸ LMNA P02545 4/20 0.85
▸ TSHR P16473 3/20 0.85
▸ SMN1; SMN2 Q16637 3/20 0.85
▸ SHBG P04278 2/20 0.85
▸ CYP3A4 P08684 2/20 0.85
▸ PMP22 Q01453 2/20 0.85
▸ ALDH1A1 P00352 2/20 0.85
▸ CYP2D6 P10635 1/20 0.85
▸ KCNA1 Q09470 1/20 0.85
▸ SLC47A1 Q96FL8 1/20 0.85
▸ FNTA P49354 5/20 0.78
▸ FNTB P49356 5/20 0.78
▸ BLM P54132 2/20 0.78
▸ MEN1 O00255 2/20 0.78
▸ KMT2A Q03164 2/20 0.78
▸ AR P10275 1/20 0.78
▸ HIF1A Q16665 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cortisone SCHEMBL10089738 0.92 HSD17B10 (1.00) HSD17B10NR3C1SERPINA6LMNATSHR
Cortisone SCHEMBL13332835 0.92 HSD17B10 (1.00) HSD17B10NR3C1SERPINA6LMNATSHR
Cortisone SCHEMBL13026135 0.92 HSD17B10 (1.00) HSD17B10NR3C1SERPINA6LMNATSHR
Cortisone SCHEMBL6535496 0.92 HSD17B10 (1.00) HSD17B10NR3C1SERPINA6LMNATSHR
Cortisone SCHEMBL9926754 0.92 HSD17B10 (1.00) HSD17B10NR3C1SERPINA6LMNATSHR
Cortisone SCHEMBL4888 0.92 HSD17B10 (1.00) HSD17B10NR3C1SERPINA6LMNATSHR
Cortisone SCHEMBL5082086 0.91 HSD17B10 (0.98) HSD17B10NR3C1SERPINA6LMNATSHR
Cortisone SCHEMBL5082082 0.91 HSD17B10 (0.98) HSD17B10NR3C1SERPINA6LMNATSHR
SCHEMBL16208665 0.91 HSD17B10 (0.83) HSD17B10NR3C1SERPINA6LMNATSHR
Cortisone SCHEMBL28537808 0.91 HSD17B10 (0.98) HSD17B10NR3C1SERPINA6LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0954323-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING A MIXTURE OF AUTOCROSS-LINKED HYALURONIC ACID AND NONAUTOCROSS-LINKED HYALURONIC ACID AND THEIR USE FOR THE TREATMENT OF ARTHROPATHIES FIDIA SPA (IT) 2004-01-07 — — EP disclosed
EP-0696598-B1 Polysaccharide esters and their salts FIDIA FARMACEUTICI (IT) 2002-11-13 — — EP disclosed
US-6251876-B1 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ARTHROPATHIES COMPRISING AUTOCROSSLINKED HYALURONIC ACID, NONCROSSLINKED HYALURONIC ACID, PHARMACEUTICALLY ACCEPTABLE EXCIPIENT, DILUENT OR CARRIER FIDIA, S.P.A. (IT) 2001-06-26 — — US disclosed
EP-0614914-B1 Crosslinked carboxy polysaccharides FIDIA SPA (IT) 2000-08-16 — — EP disclosed
EP-0954323-A1 AUTOCROSS-LINKED HYALURONIC ACID AND RELATED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ARTHROPATHIES FIDIA S.p.A. (IT) 1999-11-10 — — EP disclosed
EP-0648229-B1 HYALURONIC ACID AND DERIVATIVES THEREOF IN INTERPENETRATING POLYMER NETWORKS (IPN) MURST ITALIAN (IT) 1998-05-06 — — EP disclosed
WO-1997049412-A1 AUTOCROSS-LINKED HYALURONIC ACID AND RELATED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ARTHROPATHIES FIDIA S.P.A. (IT) 1997-12-31 — — WO disclosed
US-5676964-A BIODEGRADABLE PLASTICS; MEDICAL EQUIPMENT; DISPOSABLE PRRODUCTS; COSMETICS; DRUGS; FOODS FIDIA, S.P.A. (IT) 1997-10-14 — — US disclosed
US-5644049-A Biomaterial comprising hyaluronic acid and derivatives thereof in interpenetrating polymer networks (IPN) M.U.R.S.T. ITALIAN MINISTRY FOR UNIVERSITITES AND SCIENTIFIC AND TECHNOLOGY RESEARCH (IT) 1997-07-01 — — US disclosed
US-5506354-A ANTIULCER, ANTITURMOR, ANTIARTHRITIC, ANTIATHEROSCLEROSIS, ANTIALLERGIC, ANTIASTHMA AGENTS THE UPJOHN COMPANY (US) 1996-04-09 — — US disclosed
US-5175281-A Antiulcer, antiinflammatory, antiischemic, antiallergen, antisecretory, wound healing agents; cardiovascular disorders THE UPJOHN COMPANY (US) 1992-12-29 — — US disclosed
US-5099019-A Central nervous system steroid derivative drugs UPJOHN COMPANY (US) 1992-03-24 — — US disclosed
US-4965353-A ESTERS OF HYALURONIC ACID; MICROCAPSULES FIDIA S.P.A. (IT) 1990-10-23 — — US disclosed
WO-1989010941-A1 CROSS-LINKED CARBOXY POLYSACCHARIDES FIDIA S.P.A. (IT) 1989-11-16 — — WO disclosed
EP-0341745-A1 Crosslinked carboxy polysaccharides FIDIA S.p.A. (IT) 1989-11-15 — — EP disclosed
US-4851521-A Esters of hyaluronic acid FIDIA, S.P.A. (IT) 1989-07-25 — — US disclosed
EP-0263213-A1 C20 Through C26 amino steroids THE UPJOHN COMPANY (US) 1988-04-13 — — EP disclosed
EP-0238545-A1 C 20? THROUGH C 26? AMINO STEROIDS. UPJOHN CO (US) 1987-09-30 — — EP disclosed
EP-0216453-A2 Esters of hyaluronic acid and their salts. FIDIA S.p.A. (IT) 1987-04-01 — — EP disclosed
WO-1987001706-A2 C20 THROUGH C26 AMINO STEROIDS THE UPJOHN COMPANY (US) 1987-03-26 — — WO disclosed
Send feedback